Stockholders' Equity Attributable to Parent of Innovation1 Biotech Inc. from 31 Aug 2014 to 29 Feb 2024

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Innovation1 Biotech Inc. quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Aug 2014 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Stockholders' Equity Attributable to Parent for the quarter ending 29 Feb 2024 was $3,337,357, a 326% decline year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,337,357 -$4,815,865 -326% 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 $3,050,257 -$5,133,593 -246% 30 Nov 2023 10-Q 06 May 2025 2024 Q2
Q3 2023 $3,429,963 -$6,282,537 -220% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q2 2023 $1,251,844 -$39,037,332 -97% 31 May 2023 10-K 17 Jan 2024 2023 FY
Q1 2023 $1,478,508 -$40,608,115 -96% 28 Feb 2023 10-Q 06 May 2025 2024 Q2
Q4 2022 $2,083,336 -$41,969,912 -95% 30 Nov 2022 10-Q 06 May 2025 2024 Q2
Q3 2022 $2,852,574 +$3,077,413 31 Aug 2022 10-Q 06 May 2025 2024 Q2
Q2 2022 $40,289,176 +$40,331,275 31 May 2022 10-K 17 Jan 2024 2023 FY
Q1 2022 $42,086,623 +$44,469,098 28 Feb 2022 10-K 17 Jan 2024 2023 FY
Q4 2021 $44,053,248 +$46,981,098 30 Nov 2021 10-K 17 Jan 2024 2023 FY
Q3 2021 $224,839 +$2,453,168 +92% 31 Aug 2021 10-K 17 Jan 2024 2023 FY
Q2 2021 $42,099 +$1,888,538 +98% 31 May 2021 10-K 15 Dec 2022 2022 FY
Q1 2021 $2,382,475 -$410,202 -21% 28 Feb 2021 10-K 15 Dec 2022 2022 FY
Q4 2020 $2,927,850 -$2,677,787 -1071% 30 Nov 2020 10-K 15 Dec 2022 2022 FY
Q3 2020 $2,678,007 -$2,710,368 -8375% 31 Aug 2020 10-K 15 Dec 2022 2022 FY
Q2 2020 $1,930,637 -$2,010,009 -2532% 31 May 2020 10-Q 13 Jul 2021 2021 Q3
Q1 2020 $1,972,273 -$2,060,113 -2345% 29 Feb 2020 10-Q 13 Jul 2021 2021 Q3
Q4 2019 $250,063 -$321,955 -448% 30 Nov 2019 10-Q 14 Apr 2021 2021 Q2
Q3 2019 $32,361 -$143,514 -82% 31 Aug 2019 10-K 10 Dec 2021 2021 FY
Q2 2019 $79,372 +$329,323 31 May 2019 10-Q 20 Jul 2020 2020 Q3
Q1 2019 $87,840 +$158,821 28 Feb 2019 10-Q 20 Jul 2020 2020 Q3
Q4 2018 $71,892 +$158,208 30 Nov 2018 10-Q 20 Apr 2020 2020 Q2
Q3 2018 $175,875 +$189,151 31 Aug 2018 10-K 15 Dec 2020 2020 FY
Q2 2018 $249,951 -$187,688 -301% 31 May 2018 10-Q 18 Jul 2019 2019 Q3
Q1 2018 $70,981 -$10,193 -17% 28 Feb 2018 10-Q 23 Apr 2018 2018 Q2
Q4 2017 $86,316 -$30,229 -54% 30 Nov 2017 10-Q 15 Apr 2019 2019 Q2
Q3 2017 $13,276 +$30,803 +70% 31 Aug 2017 10-K 17 Dec 2019 2019 FY
Q2 2017 $62,263 -$25,183 -68% 31 May 2017 10-Q 24 Jul 2017 2017 Q3
Q1 2017 $60,788 -$34,690 -133% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 $56,087 -$35,153 -168% 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 $44,079 -$30,989 -237% 31 Aug 2016 10-K/A 19 Jan 2018 2017 FY
Q2 2016 $37,080 31 May 2016 10-Q 07 Oct 2016 2016 Q3
Q1 2016 $26,098 29 Feb 2016 10-Q 26 Sep 2016 2016 Q2
Q4 2015 $20,934 30 Nov 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 $13,090 -$9,523 -267% 31 Aug 2015 10-K/A 19 Jan 2018 2017 FY
Q3 2014 $3,567 31 Aug 2014 10-K/A 19 Jan 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.